Status:
COMPLETED
The Effect of Vitamin D Supplementation on COVID-19 Recovery
Lead Sponsor:
University of Monastir
Collaborating Sponsors:
Loussaief Chawki
Nissaf Ben Alaya
Conditions:
Covid19
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The COVID-19 caused by SARS-CoV-2 has transmitted quickly as a global public health emergency. The median duration for Sars-CoV-2 carrying in COVID-19 patients was 20 days (IQR 16-28) What is the role...
Detailed Description
Introduction In 2020 The world is incurring coronavirus pandemic. The epidemic of the new coronavirus started in Wuhan, China, in late 2019, originally called 2019-nCoV and then COVID-19 by the World ...
Eligibility Criteria
Inclusion
- patients with COVID 19 and having a positive RT-PCR at control in
- 14 days from confirmation of infection for asymptomatic subjects and
- 7 days after the disappearance of symptoms for pauci-symptomatic subjects
- Non inclusion Criteria: Pregnant women and children under the age of 18 will not be included
Exclusion
- None
Key Trial Info
Start Date :
April 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04883203
Start Date
April 22 2020
End Date
October 31 2020
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asma Sriha Belguit
Monastir, Tunisia, 5000